R. Alta Charo was appointed to serve on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee for the National Academies' Institute of Medicine. The committee will determine if gene transfer research raises issues of concern that warrant extra oversight by the Recombinant DNA Advisory Committee of individual clinical trial protocols involving gene transfer technique and will describe the criteria used in making this determination.

Submitted by Law School News on May 9, 2013

This article appears in the categories: Activities & Scholarship